Chen J, Jiang H, Wu Y, Li Y, & Gao Y. (2022). A Novel Glycyrrhetinic Acid-Modified Oxaliplatin Liposome for Liver-Targeting and in vitro/vivo Evaluation [Retraction]. Dove Medical Press.
Chicago Style (17th ed.) CitationChen J, Jiang H, Wu Y, Li Y, and Gao Y. A Novel Glycyrrhetinic Acid-Modified Oxaliplatin Liposome for Liver-Targeting and in Vitro/vivo Evaluation [Retraction]. Dove Medical Press, 2022.
MLA (9th ed.) CitationChen J, et al. A Novel Glycyrrhetinic Acid-Modified Oxaliplatin Liposome for Liver-Targeting and in Vitro/vivo Evaluation [Retraction]. Dove Medical Press, 2022.
Warning: These citations may not always be 100% accurate.